H. Worth (Fürth, Germany), C. Vogelmeier (Marburg, Germany)
LATE-BREAKING ABSTRACT: The coagulant factor Xa induces PAR-1 and annexin A2-dependent airway smooth muscle cytokine production and cell proliferation.
M. Schuliga, T. Harris, S. Royce, A. Stewart (Parkville, Clayton, Australia)
|  |
LATE-BREAKING ABSTRACT: Airway remodelling induced by ADAM33 is reversible
E. R Davies, L. Zhang, S. T Holgate, D. E Davies, J. A. Whitsett, H. M. Haitchi (Southampton, United Kingdom; Cincinnati, United States Of America)
| |
Increased MUC5B and carbonic anhydrase IX expression in the bronchial epithelium of COPD persistent sputum producers
S. Khurana, K. Brown, J. Vestbo, J. Plumb, D. Singh (Manchester, United Kingdom)
| |
Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
S. Elsawy, S. Abu Bakr, S. Oraby, T. Saied, O. Abu Elkhair (Cairo, Egypt)
|  |
Characteristics of essential hypertension in COPD patients
Z. Nersesyan, S. Ovcharenko, T. Morozova (Moscow, Russian Federation)
| |
Plasma surfactant protein D (SP-D) and smoking status in patients with COPD
K. Gashynova (Dnipropetrovsk, Ukraine)
| |
Effect of travelling to 2590m on 6-minute walk distance, blood gases and symptoms of acute mountain sickness in COPD patients
T. D. Latshang, M. Furian, D. Flück, S. D. Segitz, C. Murer, P. Scheiwiller, S. Mueller-Mottet, B. Osmonov, S. M. Kueest, A. Steiner, S. Ulrich, T. Rothe, S. E. Hartmann, M. J. Poulin, M. Kohler, K. E. Bloch (Zurich, Davos Clavadel, Switzerland; Calgary, Canada; Bishkek, Kyrgyzstan)
| |
Features of systemic inflammation in patients with stable COPD
N. Sanina, S. Panina (Dnipropetrovs'k, Ukraine)
| |
A disease-specific integrated care intervention (ICI) prevents hospital admission only in COPD patients with recurrent hospitalisation
A. Porcu, F. Costa, M. Polselli, A. Macuzzi, B. Marsiglia, A. Casani, M. Moretti (Carrara, Italy)
| |
Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
M. Barrecheguren, C. Martínez, E. Naval, P. García-Sidro, M. Bonnin, J. L. García-Rivero, R. Malo de Molina, P. J. Marcos, J. M. Diez, A. Herrejon, J. A. Ros, S. Mayoralas, M. Valle, M. Miravitlles (Barcelona, Valencia, Villarreal, Girona, Cantabria, Madrid, A Coruña, Murcia, Spain)
| |
Individual dynamic of inflammatory markers as indicators of COPD treatment effectiveness
L. Konopkina, B. Basina (Dnipropetrovsk, Ukraine)
| |
To improvement of diagnostics of the diabetes mellitus 2 type at patients with chronic obstructive pathology of lungs
V. Kobylyanskiy, G. Babajanova (Moskow, Russian Federation)
| |
Identification of nasal virus infection in patients with COPD exacerbations
I. Strambu, I. Stoicescu, M. Burecu, D. Dospinoiu, C. Nita, F. Cojocaru, A. Croitoru, D. Ionita (Bucharest, Romania)
| |
National trends in utilization and outcomes of percutaneous coronary intervention (PCI) among patients with and without COPD in Spain (2001-2011)
J. de Miguel Díez, R. Jiménez García, M. Llanos Flores, V. Hernández Barrera, A. López de Andrés, A. Oliva Ramos, I. Jarana Aparicio, J. C. Vargas Espinal, L. Puente Maestu, P. Carrasco Garrido (Madrid, Alcorcón, Spain)
| |
COPD as undetected cause of dyspnea in patients admitted with ischaemic heart disease (IHD)
D. Mihailichenko, T. Pertseva (Dnipropetrovsk, Ukraine)
| |
Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD)
E. Kochetova (Petrozavodsk, Russian Federation)
| |
Relationship between dyspnea and depression in the elderly patients with chronic obstructive pulmonary disease
J. S. Choi, Y. I. Kim, H. S. Lee, K. H. Seo, J. O. Na, Y. H. Kim, H. Y. Lee (Cheonan, Republic Of Korea)
| |